Literature DB >> 2003575

Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells.

M Pinzani1, T C Knauss, G F Pierce, P Hsieh, W Kenney, G R Dubyak, H E Abboud.   

Abstract

Platelet-derived growth factor (PDGF), a key mitogen for liver fat-storing cells (FSC), is a dimeric molecule that occurs as homodimers or heterodimers of related polypeptide chains (PDGF-BB, -AB, and -AA). In chronic inflammation of the liver lobule, any of the three dimeric forms of PDGF derived from multiple sources could potentially interact with FSC. We explored the effects of the three different PDGF isoforms on DNA synthesis and early signal transduction pathways potentially related to PDGF mitogenicity in rat liver FSC. PDGF-BB homodimer and -AB heterodimer induced a marked increase in DNA synthesis, whereas the effect of PDGF-AA homodimer was considerably lower. Moreover, the mitogenicity of each isoform proportionally correlated with their effects on phosphoinositide turnover and intracellular Ca2+. Both the PDGF-BB and -AB dimers likely interact with the PDGF-beta-receptor, although PDGF-AB requires at least one alpha-receptor. The low responsiveness to PDGF-AA could not be accounted for by downregulation of the PDGF-alpha-receptor because FSC expressed very low levels of PDGF-A- and B-chain mRNAs and did not secrete detectable amounts of PDGF activity in the conditioned media. In addition, preincubation of FSC with suramin, a potent inhibitor of PDGF binding to its receptor, failed to increase PDGF-AA-induced DNA synthesis. These results are consistent with a predominant expression of PDGF-beta-receptor in liver FSC, that is linked to phospholipase C activation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2003575     DOI: 10.1152/ajpcell.1991.260.3.C485

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

1.  Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis.

Authors:  M V Apte; P S Haber; S J Darby; S C Rodgers; G W McCaughan; M A Korsten; R C Pirola; J S Wilson
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

2.  Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients.

Authors:  M Pinzani; P Failli; C Ruocco; A Casini; S Milani; E Baldi; A Giotti; P Gentilini
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease.

Authors:  Y Ikura; H Morimoto; M Ogami; H Jomura; N Ikeoka; M Sakurai
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

4.  Platelet-Derived Growth Factor Receptor α Contributes to Human Hepatic Stellate Cell Proliferation and Migration.

Authors:  Alexander Kikuchi; Tirthadipa Pradhan-Sundd; Sucha Singh; Shanmugam Nagarajan; Nick Loizos; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2017-07-20       Impact factor: 4.307

5.  YKL-40 expression in CD14⁺ liver cells in acute and chronic injury.

Authors:  Oscar Pizano-Martínez; Irinea Yañez-Sánchez; Pilar Alatorre-Carranza; Alejandra Miranda-Díaz; Pablo C Ortiz-Lazareno; Trinidad García-Iglesias; Adrian Daneri-Navarro; Mónica Vázquez-Del Mercado; Mary Fafutis-Morris; Vidal Delgado-Rizo
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

6.  Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis.

Authors:  M Pinzani; S Milani; H Herbst; R DeFranco; C Grappone; A Gentilini; A Caligiuri; G Pellegrini; D V Ngo; R G Romanelli; P Gentilini
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

7.  Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells.

Authors:  M Pinzani; F Marra; A Caligiuri; R DeFranco; A Gentilini; P Failli; P Gentilini
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

8.  Inhibitory effects of rapamycin on the different stages of hepatic fibrosis.

Authors:  Yun Jeung Kim; Eaum Seok Lee; Seok Hyun Kim; Heon Young Lee; Seung Moo Noh; Dae Young Kang; Byung Seok Lee
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

9.  Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis.

Authors:  Chundong Yu; Fen Wang; Chengliu Jin; Xinqiang Huang; David L Miller; Claudio Basilico; Wallace L McKeehan
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

10.  Expression of platelet-derived growth factor-BB in liver tissues of patients with chronic hepatitis B.

Authors:  Song-Mei Lou; You-Ming Li; Kai-Ming Wang; Wei-Min Cai; Hong-Lei Weng
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.